Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Peritoneal Mesothelioma”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Not applicableStudy completedNCT01812148
What this trial is testing

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Who this might be right for
Peritoneal Mesotheliomas
Maisonneuve-Rosemont Hospital 19
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Testing effectiveness (Phase 2)Study completedNCT00859469
What this trial is testing

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

Who this might be right for
Mesothelioma
Columbia University 29
Testing effectiveness (Phase 2)Looking for participantsNCT06057935
What this trial is testing

Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Who this might be right for
Malignant Peritoneal MesotheliomaPeritoneal MesotheliomaMesothelioma+2 more
Memorial Sloan Kettering Cancer Center 64
Not applicableUnknownNCT03210298
What this trial is testing

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Who this might be right for
Peritoneum CancerPeritoneum NeoplasmPleural Cancer+12 more
Sabine Rhode 1,000
Testing effectiveness (Phase 2)Study completedNCT05449366
What this trial is testing

Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma

Who this might be right for
Peritoneal Malignant Mesothelioma
Erasmus Medical Center 7
Not applicableLooking for participantsNCT07330271
What this trial is testing

PTC-Guided Therapy for Peritoneal Mesothelioma

Who this might be right for
Peritoneal Mesothelioma
Beijing Tsinghua Chang Gung Hospital 347
Early research (Phase 1)Study completedNCT00402766
What this trial is testing

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

Who this might be right for
Mesothelioma
M.D. Anderson Cancer Center 19
Not applicableLooking for participantsNCT01416714
What this trial is testing

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

Who this might be right for
Gastric Cancers
University of Chicago 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06790706
What this trial is testing

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Who this might be right for
Peritoneal MesotheliomaGestational Trophoblastic TumorThymoma and Thymic Carcinoma+3 more
Hospices Civils de Lyon 154
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT02535312
What this trial is testing

Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

Who this might be right for
Advanced Malignant Solid NeoplasmAdvanced Peritoneal Malignant MesotheliomaAdvanced Pleural Malignant Mesothelioma+4 more
National Cancer Institute (NCI)
Not applicableUnknownNCT05185791
What this trial is testing

ERAS® Guidelines Validation of CRS With or Without HIPEC

Who this might be right for
Peritoneal Diseases
Hospices Civils de Lyon 288
Testing effectiveness (Phase 2)UnknownNCT00024271
What this trial is testing

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Who this might be right for
Malignant Mesothelioma
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05001880
What this trial is testing

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Who this might be right for
Peritoneal Malignant Mesothelioma
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT05041062
What this trial is testing

Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

Who this might be right for
MesotheliomaPeritoneal Mesothelioma
University of Chicago 2
Early research (Phase 1)Ended earlyNCT03608618
What this trial is testing

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

Who this might be right for
Peritoneal MesotheliomaFallopian Tube AdenocarcinomaAdenocarcinoma of the Ovary+1 more
MaxCyte, Inc. 14
Not applicableStudy completedNCT02834234
What this trial is testing

Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays

Who this might be right for
Peritoneal Mesothelioma
Hospices Civils de Lyon 33
Load More Results
30